--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
Feb 25, 20252024/Q40.000 / 0.000--
Nov 13, 20242024/Q30.000 / 0.000--
Jul 31, 20242024/Q280.000M / 41.113M--
Tesla
TSLA
NVIDIA
NVDA
Strategy
MSTR
4
Palantir
PLTR
5
Coinbase
COIN
US Stock MarketDetailed Quotes
FULC Fulcrum Therapeutics
- 3.590
- +0.220+6.53%
Close Feb 28 16:00 ET
- 3.590
- 0.0000.00%
Post 19:55 ET
193.79MMarket Cap-22.44P/E (TTM)
3.615High3.270Low368.52KVolume3.360Open3.370Pre Close1.29MTurnover1.39%Turnover RatioLossP/E (Static)53.98MShares13.70052wk High0.80P/B95.15MFloat Cap2.86052wk Low--Dividend TTM26.50MShs Float33.098Historical High--Div YieldTTM10.24%Amplitude2.250Historical Low3.512Avg Price1Lot Size
Fulcrum Therapeutics Key Stats
Fulcrum Therapeutics Q4 2024 Earnings Date
Currency：USDFeb 25, 2025
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| EPS | -0.28 | -0.31 | -0.03 |
| Miss Est. | +29.58% | +22.50% | -10.09% |
| Net Income | -- | -16.57M | -- |
+33.07% |
Analyst Rating
Feb 28, 2025
Fulcrum Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Fulcrum Therapeutics Earnings Reports
Read more